Comparison of sulbactam/ampicillin and cefuroxime in infections of the lower respiratory tract: Results of a prospective, randomized and comparative study

International Journal of Antimicrobial Agents

Volumn 6, Issue SUPPL.1, 1996, Pages

  Schwigon, C D ^a   Cuhorst, R ^b   Gabor, M ^c   Zinndorf, J ^d   Springsklee, M ^e  

^a Berlin Zehlendorf Hospital   (Germany)

^b Pneumology Unit   (Germany)

^c Internal Medicine Unit   (Germany)

^d Intensive Care Unit   (Germany)

^e PFIZER INC   (United States)

Author keywords

Ampicillin; Cefuroxime; Lower respiratory tract; Sulbactam

Indexed keywords

EID: 4243254801     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(96)80011-2     Document Type: Article

References (24)

1. Simon C, Stille W. Infektionen des Respirationstraktes. In: Anti-biotika-Therapie in Klinik und Praxis, 7. Aufl. Schattauer, Stuttgart, 1989, pp. 78-80, 454-461.
2. Finegold SM, Kirby WM. Introduction: changing patterns of hospital infections: implications for therapy. Am J Med 1984; 77(suppl. 1B):1-2.
3. Finegold SM, Johnson CC. Lower respiratory tract infection. Am J Med 1985;79(suppl. B):73-77.
4. Füssle R, Biscoping J, Michaelis G, Menges Th, Sziegoleit A. Kooperative Betreuung von Intensivpatienten. Chemother J 1992;1:99-103.
5. Neu HC. The emergence of bacterial resistance and its influence on empiric therapy. Rev Infect Dis 1983;5(suppl. 1):S9-S20.
6. Williams ID. Importance of β-lactamases and clinical implications of their inhibitors. Drugs 1988;35(suppl. 7):3-11.
7. Brogden RN, Heel RC, Speight TM, Avery GS. Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1979;17:233-266.
8. English AR, Retsema JA, Girard AE, Lynch JE, Barth WE. CP 45,899, a β-lactamase inhibitor that extends the antibacterial spectrum of β-lactams: initial bacteriological characterization. Antimicrob Agents Chemother 1978;14:414-419.
9. Grimm H. The in vitro activity of sulbactam/ampicillin. In: Ueda Y, Neu HC (eds) β-Lactamase Blocking Agents. Proc Workshop 14th Int Congr Chemotherapy, Kyoto, 1985. University of Tokyo Press, Tokyo, 1986.
10. Heizmann W, Heilmann F, Werner H. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin. Infection 1987;15:370-374.
11. Neu HC, Fu KP. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of Gram-positive and -negative activity. Antimicrob Agents Chemother 1978;13:657-664.
12. Aswapokee N, Neu HC. A sulfone β-lactam compound which acts as a β-lactamase inhibitor. J Antibiot (Tokyo) 1978;31:1238-1244.
13. Labia R, Morand A, Lelievre V, Mattioni D, Kazmierczak A. Sulbactam: biochemical factors involved in its synergy with ampicillin. Rev Infect Dis 1986;8(suppl. 5):496-502.
14. Retsema JA, English AR, Girard AE. CP-45,899 in combination with penicillin or ampicillin-resistant Staphylococcus, Haemophilus influenzae and Bacteroides. Chemother 1980;17:615-622.
15. Retsema JA, English AR, Girard AE, Anderson M, Brennan L, Cimochowski L, Faiella I, Herbert C. Sulbactam and ampicillin: synergistic activity against hospital isolates of Enterobacteriaceae, methicillin-resistant Staphylococcus, and anaerobes. In: Proc 13th Int Congr Chemotherapy, Vienna, 1983, pp. 23/1-23/5.
16. Beale AS, Gisby J. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection. J Antimicrob Chemother 1989;24:29-37.
17. Naber KG, Wittenberger R. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or ampicillin against bacteria isolated from patients with complicated urinary tract infections. Rev Infect Dis 1986;8(suppl. 5):5604-5608.
18. Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA 1975;234:1236-1241.
19. Lees L, Milson JA, Knirsch AK, Greenhalgh K. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use. Rev Infect Dis 1986;8(suppl. 5):644-650.
20. Lode H, Springsklee M. Klinische Ergebnisse mit Sulbactam/ Ampicillin in einer multizentrischen Studie an 425 Patientien. Med Klin 1989;84:236-241.
21. Springsklee M, Lode H. Therapie von Infektionen des unteren Respirationstraktes mit Sulbactam/Ampicillin. Münch Med Wschr 1990;132:146-150.
22. Valcke Y, Van der Straeten M. A non comparative study of the safety and efficacy of patenteral sulbactam/ampicillin followed by oral sultamicillin for the treatment of lower respiratory tract infections. Curr Ther Res 1989;45:43-17.
23. Yangco BG, Kenyon VS, Halkias KD, Toney IF, Chmel H. Comparative evaluation of safety and efficacy of cefmetazole and cefoxitin in lower respiratory tract infections. J Antimicrob Chemother 1989;23(suppl. D):39-46.
24. Maesen FPV, Davies BI, Baur C, Sumajov CA. Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease. J Antimicrob Chemother 1986;18:629-634.